These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8282140)

  • 41. [Local administration of low-dose estriol and vital Lactobacillus acidophilus in postmenopause].
    Kanne B; Jenny J
    Gynakol Rundsch; 1991; 31(1):7-13. PubMed ID: 1906830
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics and preliminary efficacy of two vaginal gel formulations of ultra-low-dose estriol in postmenopausal women.
    Delgado JL; Estevez J; Radicioni M; Loprete L; Moscoso Del Prado J; Nieto Magro C
    Climacteric; 2016 Apr; 19(2):172-80. PubMed ID: 26786399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oestriol in the prophylactic treatment of recurrent urinary tract infections in postmenopausal women.
    Kirkengen AL; Andersen P; Gjersøe E; Johannessen GR; Johnsen N; Bodd E
    Scand J Prim Health Care; 1992 Jun; 10(2):139-42. PubMed ID: 1641524
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Occurrence, nature and treatment of urinary incontinence in a 70-year-old female population.
    Samsioe G; Jansson I; Mellström D; Svanborg A
    Maturitas; 1985 Nov; 7(4):335-42. PubMed ID: 3908884
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of climacteric urogenital disorders with an estriol-containing ointment].
    Koloszár S; Kovács L
    Orv Hetil; 1995 Feb; 136(7):343-5. PubMed ID: 7870416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oxytocin improves cytological and histological profiles of vaginal atrophy in postmenopausal women.
    Al-Saqi SH; Jonasson AF; Naessén T; Uvnäs-Moberg K
    Post Reprod Health; 2016 Mar; 22(1):25-33. PubMed ID: 26883689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oestriol in the treatment of postmenopausal urgency: a multicentre study.
    Cardozo L; Rekers H; Tapp A; Barnick C; Shepherd A; Schussler B; Kerr-Wilson R; van Geelan J; Barlebo H; Walter S
    Maturitas; 1993 Dec; 18(1):47-53. PubMed ID: 8107615
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of ultralow topical estriol dose on vaginal health and quality of life in postmenopausal women who underwent surgical treatment for pelvic organ prolapse.
    Caruso S; Cianci S; Vitale SG; Matarazzo MG; Amore FF; Cianci A
    Menopause; 2017 Aug; 24(8):900-907. PubMed ID: 28350758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women.
    Simon JA; Reape KZ; Wininger S; Hait H
    Fertil Steril; 2008 Oct; 90(4):1132-8. PubMed ID: 18053998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estrogen therapy influence on periurethral vessels in postmenopausal incontinent women using Dopplervelocimetry analysis.
    Kobata SA; Girão MJ; Baracat EC; Kajikawa M; Di Bella V; Sartori MG; Jármy-Di Bella ZI
    Maturitas; 2008 Nov; 61(3):243-7. PubMed ID: 18845407
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short-term urogenital effects of raloxifene, tamoxifen, and estrogen.
    Vardy MD; Lindsay R; Scotti RJ; Mikhail M; Richart RM; Nieves J; Zion M; Cosman F
    Am J Obstet Gynecol; 2003 Jul; 189(1):81-8. PubMed ID: 12861143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of oral oestriol on vaginal flora and cytology and urogenital symptoms in the post-menopause.
    Molander U; Milsom I; Ekelund P; Mellström D; Eriksson O
    Maturitas; 1990 Jun; 12(2):113-20. PubMed ID: 2255263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Intravesical administration of estriol in sensory urge incontinence--a prospective study].
    Kurz C; Nagele F; Sevelda P; Enzelsberger H
    Geburtshilfe Frauenheilkd; 1993 Aug; 53(8):535-8. PubMed ID: 8375632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Local estrogen therapy--clinical implications--2012 update].
    Kokot-Kierepa M; Bartuzi A; Kulik-Rechberger B; Rechberger T
    Ginekol Pol; 2012 Oct; 83(10):772-7. PubMed ID: 23383564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of chronic cystitis in postmenopausal women].
    Davidov MI; Petruniaev AI; Bunova NE
    Urologiia; 2009; (4):14-9. PubMed ID: 19824379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause?
    Matarazzo MG; Caruso S; Giunta G; Valenti G; Sarpietro G; Cianci A
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():75-79. PubMed ID: 29367168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy.
    Dugal R; Hesla K; Sørdal T; Aase KH; Lilleeidet O; Wickstrøm E
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):293-7. PubMed ID: 10746845
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of vaginally administered genistein in comparison with hyaluronic acid on atrophic epithelium in postmenopause.
    Le Donne M; Caruso C; Mancuso A; Costa G; Iemmo R; Pizzimenti G; Cavallari V
    Arch Gynecol Obstet; 2011 Jun; 283(6):1319-23. PubMed ID: 20577750
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of a soy rich diet on the vaginal epithelium in postmenopause: a randomized double blind trial.
    Chiechi LM; Putignano G; Guerra V; Schiavelli MP; Cisternino AM; Carriero C
    Maturitas; 2003 Aug; 45(4):241-6. PubMed ID: 12927310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effective treatment of vaginal atrophy with isoflavone vaginal gel.
    Lima SM; Yamada SS; Reis BF; Postigo S; Galvão da Silva MA; Aoki T
    Maturitas; 2013 Mar; 74(3):252-8. PubMed ID: 23312487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.